Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company
Rhea-AI Summary
Helius Medical Technologies (NASDAQ:HSDT) has successfully closed a private placement offering, raising over $500 million with potential to reach $1.25 billion through warrant exercises. The offering includes common stock and stapled warrants at $6.881 per share, with warrants exercisable at $10.134 for three years.
Led by Pantera Capital and Summer Capital, the company will implement a digital asset treasury strategy focused on acquiring SOL, Solana's native cryptocurrency. The company appointed Joseph Chee as Executive Chairman and brought in key strategic advisors from Pantera Capital.
Solana processes over 3,500 transactions per second, averages 3.7 million daily active wallets, and offers a 7% native staking yield. HSDT aims to become the premier SOL-backed treasury vehicle, following similar models to MSTR (Bitcoin) and BMNR (Ethereum).
Positive
- Substantial funding secured with $500 million raised and potential for $1.25 billion total through warrant exercises
- Strategic partnership with major crypto investors Pantera Capital and Summer Capital
- Appointment of experienced leadership including Joseph Chee as Executive Chairman
- Investment in SOL offers 7% native staking yield potential
- High trading liquidity with over $500 million cumulative trading volume since strategy announcement
Negative
- Significant dilution risk from warrant exercises at $10.134 per share
- High exposure to crypto market volatility through SOL concentration
- Regulatory uncertainty in cryptocurrency investments
- Securities offered are restricted and not registered under Securities Act
News Market Reaction
On the day this news was published, HSDT gained 1.85%, reflecting a mild positive market reaction. Argus tracked a peak move of +16.8% during that session. Our momentum scanner triggered 14 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $499K to the company's valuation, bringing the market cap to $27M at that time.
Data tracked by StockTitan Argus on the day of publication.
Preeminent SOL-backed treasury vehicle - with potential to raise over
The financing drew participation from leading investors across traditional finance and crypto, including Big Brain Holdings, Avenir, SinoHope, FalconX, Arrington Capital, Animoca Brands, Aspen Digital, Borderless, Laser Digital, HashKey Capital, and Republic Digital
The Offering was led by Pantera Capital, the first
The Company intends to use the net proceeds of the Offering to implement a digital asset treasury strategy and acquire SOL, the native cryptocurrency of the Solana blockchain. SOL will serve as the Company's primary treasury reserve asset. Solana has historically been the fastest growing blockchain, leading the industry in transaction revenue and processing more than 3,500 transactions per second. The network is also the most widely adopted, averaging about 3.7 million daily active wallets and surpassing 23 billion transactions year to date. SOL is financially productive by design, offering a ~
In addition, upon the closing, the Company appointed Joseph Chee (Founder and Chairman of Summer Capital and Former Head of Investment Banking,
"We're offering investors public-market exposure to Solana, which we view as the most commercially viable blockchain today. Its adoption journey is still in its early stages. Pantera pioneered the crypto fund industry in the
"HSDT has had over
"We are thrilled to join forces with a leadership team laser-focused on maximizing SOL per share by leveraging the most commercially viable blockchain for decentralized finance and consumer applications," said Joseph Chee, Founder and Chairman of Summer Capital. "Our thesis is that all capital markets transactions, from tokenization to payments, are moving onto blockchain rails, and Helius aims to bridge public markets with the Solana network, where we expect the majority of that activity to take place."
SOL Treasury Strategy and Institutional Roadmap
In the coming months, the Company expects to:
- Build an initial SOL position with plans to significantly scale holdings over the next 12–24 months via a best-in-class capital markets program, incorporating ATM sales and other proven strategies.
- Evaluate staking, lending and other opportunities throughout the ecosystem to generate revenue from the SOL Treasury, while maintaining a conservative risk profile.
The Company's common stock will continue to trade on the Nasdaq Capital Market under the ticker "HSDT", with the updated treasury strategy effective immediately following the closing.
The Company will emphasize transparency and verification of holdings, strong engagement with the SOL ecosystem and community. Additional updates on the Offering, SOL acquisitions, treasury growth, relevant stockholder approvals and governance measures are expected in the coming weeks.
Advisors
Clear Street served as the exclusive financial advisor and lead placement agent to the Company, and Maxim Group LLC and Tiger Securities acted as co-placement agents to the Company. Honigman LLP served as counsel to the Company. Reed Smith LLP served as counsel to Pantera Capital. Cooley LLP served as counsel to Summer Capital. Winston & Strawn LLP served as counsel to Clear Street.
Securities Disclaimers:
The information provided in this press release is intended for informational purposes only and does not constitute investment advice, endorsement, analysis, or recommendations with respect to any financial instruments, investments, or issuers. Investment in cryptocurrency and DeFi projects involves substantial risk, including the risk of complete loss. This press release does not take into account the investment objectives, financial situation, or specific needs of any particular person and each individual is urged to consult their legal and financial advisors before making any investment decisions.
The offer and sale of the securities in the Offering, including the shares of common stock underlying the pre-funded warrants, was made to institutional accredited investors in a transaction not involving a public offering pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the "Securities Act") and/or Rule 506(b) of Regulation D promulgated thereunder, and have not been registered under the Securities Act or applicable state securities laws. Accordingly, the securities issued in the Offering and shares of common stock underlying the pre-funded warrants may not be offered or sold in
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
The private placement was conducted in accordance with applicable Nasdaq rules and was priced to satisfy the "Minimum Price" requirement (as defined in the Nasdaq rules).
About Helius Medical Technologies, Inc.
Helius Medical Technologies is a leading neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the brain's ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing with neurologic diseases. The Company's first commercial product is the Portable Neuromodulation Stimulator. For more information about the PoNS® or Helius Medical Technologies, visit www.heliusmedical.com.
About Pantera Capital Management LP
Pantera Capital is the first institutional investment firm focused exclusively on bitcoin, other digital currencies, and companies in the blockchain tech ecosystem. Pantera launched the first cryptocurrency fund in
Demonstrating leadership in the Digital Asset Token (DAT) space, Pantera has invested in the first
About Summer Capital Limited
Summer Capital is a prominent investment management and advisory firm with operations spanning
Summer Capital leverages longstanding relationships to access historically under-allocated institutional capital in
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements" within the meaning of the
These forward-looking statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown risks, uncertainties, and other factors—many of which are beyond the Company's control—that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. Important factors that may affect actual results include, among others, the Company's ability to execute its growth strategy; its ability to raise and deploy capital effectively; developments in technology and the competitive landscape; the market performance of SOL; and other risks and uncertainties described under "Risk Factors" in the Company's Annual Report on Form 10-K filed with the SEC on March 25, 2025, and in other subsequent filings with the SEC. These filings are available at www.sec.gov. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.
Twitter/X: @HeliusHSDT
Website: https://www.helius.company/
Linkedin: https://www.linkedin.com/company/helius-solana-company/
Media Contacts: | |||
Helius Medical Technologies, Inc. | Philip Trip Taylor Gilmartin Group | ||
Pantera Capital Management LP | ir@panteracapital.com press@panteracapital.com | ||
View original content to download multimedia:https://www.prnewswire.com/news-releases/helius-nasdaqhsdt-in-partnership-with-pantera-capital-and-summer-capital-closes-over-500-million-private-placement-to-launch-sol-treasury-company-302560967.html
SOURCE Pantera Capital